Plant drugs in the twenty-first century

Abstract

Lack of effective cooperation among researchers in the applicable biological, physical, and clinical sciences has accounted, in large measure, for the lack of successful development in the United States of any significant number of new plant drugs during the latter part of the 20th century. Unrealistic federal regulations that tend to render unprofitable such research have also played an important role in hindering the development of new plant drugs. It is likely that both of these factors will change in the future as health-conscious consumers demand more accurate information and wider availability of natural drug products. Several anticipated developments will greatly facilitate research and production in this previously difficult area. These include the development of new, simplified bioassay procedures; improved, easily applied analytical methods; and innovative plant-cell-culture methodologies, possibly involving genetic manipulation. The kinds of drugs that need to be developed using such techniques are discussed. It is concluded that significant new plant drugs and new methods of producing them will be developed to serve mankind during the 21st century.